A retrospective study conducted in Eastern China revealed that HER2 amplification was related to more extensive invasion of intestinal wall and higher TNM stage in CRC patients with stages I–III [21], while other reports did not find such association [27,41]. This evidence concerns the gene ERBB2 and colorectal carcinoma.